Effect of Cardiac Resynchronization Therapy on Myocardial Fibrosis and Relevant Cytokines in a Canine Model With Experimental Heart Failure
Authors:
- 6 March 2017
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 28 (4) , 438-445
Abstract
CRT and Myocardial Fibrosis: Introduction: Though cardiac resynchronization therapy (CRT) has now proved to be effective on cardiac reverse remodeling, data on the underlying molecular changes are limited. The present study aims to investigate the expression of cytokines concerning myocardial fibrosis in dyssynchronous heart failure (HF) and the potential benefits of CRT.Methods and Results: Left bundle branch ablation and rapid pacing was performed to induce a canine model of asynchronous HF. Animals were randomly divided into sham group, HF control group, and CRT group. Echocardiographic data including septum‐to‐posterior wall motion delay (SPWMD) and standard deviation of the time to peak systolic velocity (Ts‐SD) were collected. Histologic samples from lateral left ventricular (LV) and right ventricular (RV) free wall were analyzed and compared among different groups. Serum concentrations of NT‐proBNP, TGF‐β1, and osteopontin (OPN) were measured using enzyme‐linked immunosorbent assay (ELISA). Protein and mRNA expressions of TGF‐β1/Smad and OPN from myocardial tissues were also detected and compared. CRT improved cardiac function and corrected intraventricular dyssynchrony with increased LV ejection fraction (LVEF) and decreased SPWMD and Ts‐SD (P < 0.05). Histological analysis showed that CRT restored cardiomyocyte diameter (from 4.50 to 6.08 μm) and collagen volume fraction (from 19.33% to 11.21%) of LV (P < 0.01), but had little effect on RV. Serum TGF‐β1 and OPN level were also reversed toward normal level after CRT (P < 0.05). Compared with sham group, a significantly higher protein and mRNA expressions of TGF‐β1/Smad and OPN were observed in HF control group, which were significantly downregulated in CRT group (P < 0.01).Conclusion: By means of coordinating LV dyssynchrony, cellular and molecular reverse remodeling relevant to fibrosis inhibition could also be invoked by CRT.Keywords
Funding Information
- National Natural Science Foundation of China (81200170)
This publication has 30 references indexed in Scilit:
- Matricellular Proteins in Cardiac Adaptation and DiseasePhysiological Reviews, 2012
- Plasma osteopontin reveals left ventricular reverse remodelling following cardiac resynchronization therapy in heart failureInternational Journal of Cardiology, 2011
- Cellular Evidence of Reverse Cardiac Remodeling Induced by Cardiac Resynchronization TherapyCongestive Heart Failure, 2011
- Cardiac Sympathetic Reserve and Response to Cardiac Resynchronization TherapyCirculation: Heart Failure, 2011
- Osteopontin: Role in extracellular matrix deposition and myocardial remodeling post-MIJournal of Molecular and Cellular Cardiology, 2010
- Electrophysiological Consequences of Dyssynchronous Heart Failure and Its Restoration by Resynchronization TherapyCirculation, 2009
- Cardiac resynchronization therapy cures dyssynchronopathy in canine left bundle-branch block heartsEuropean Heart Journal, 2007
- The role of TGF-β signaling in myocardial infarction and cardiac remodelingCardiovascular Research, 2007
- Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study: Table 1Heart, 2006
- Canine Nonischemic Left Ventricular Dysfunction: A Model of Chronic Human CardiomyopathyJournal of Cardiac Failure, 2005